Seguir
Peter van de Kerkhof
Peter van de Kerkhof
radboud
Dirección de correo verificada de radboudumc.nl
Título
Citado por
Citado por
Año
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ...
Nature genetics 44 (12), 1341-1348, 2012
10452012
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
CEM Griffiths, BE Strober, P Van De Kerkhof, V Ho, R Fidelus-Gort, ...
New England Journal of Medicine 362 (2), 118-128, 2010
10272010
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ...
Journal of the European Academy of Dermatology and Venereology 23 (SUPPL. 2 …, 2009
9552009
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
CEM Griffiths, K Reich, M Lebwohl, P Van De Kerkhof, C Paul, A Menter, ...
The Lancet 386 (9993), 541-551, 2015
8622015
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions
BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ...
Journal of Investigative Dermatology 130 (7), 1785-1796, 2010
8622010
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
KA Papp, S Tyring, M Lahfa, J Prinz, CEM Griffiths, AM Nakanishi, R Zitnik, ...
British Journal of Dermatology 152 (6), 1304-1312, 2005
8552005
Psoriasis is associated with increased β-defensin genomic copy number
EJ Hollox, U Huffmeier, PLJM Zeeuwen, R Palla, J Lascorz, ...
Nature genetics 40 (1), 23-25, 2008
8162008
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
5632014
European S3-guidelines on the systemic treatment of psoriasis vulgaris-update 2015-short version-EDF in cooperation with EADV and IPC
A Nast, P Gisondi, AD Ormerod, P Saiag, CH Smith, PI Spuls, ...
Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015
5322015
Leg ulcers: a review of their impact on daily life
A Persoon, MM Heinen, CJM Van Der Vleuten, MJ De Rooij, ...
Journal of Clinical Nursing 13 (3), 341-354, 2004
5022004
Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin
HJ Bovenschen, PC Van De Kerkhof, PE Van Erp, R Woestenenk, ...
Journal of Investigative Dermatology 131 (9), 1853-1860, 2011
4902011
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
L Dubertret, U Mrowietz, A Ranki, PCM Van De Kerkhof, S Chimenti, ...
British Journal of Dermatology 155 (4), 729-736, 2006
4692006
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
H Bachelez, PCM Van De Kerkhof, R Strohal, A Kubanov, F Valenzuela, ...
The Lancet 386 (9993), 552-561, 2015
4272015
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
K Kragballe, BT Gjertsen, D De Hoop, PCM Van de Kerkhof, T Karlsmark, ...
The Lancet 337 (8735), 193-196, 1991
4271991
European consensus statement on phenotypes of pustular psoriasis
AA Navarini, AD Burden, F Capon, U Mrowietz, L Puig, S Köks, K Kingo, ...
Journal of the European Academy of Dermatology and Venereology 31 (11), 1792 …, 2017
4092017
Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients
E De Jong, B Seegers, MK Gulinck, JBM Boezeman, PCM Van de Kerkhof
Dermatology 193 (4), 300-303, 1996
3861996
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis
GJ de Jongh, PLJM Zeeuwen, M Kucharekova, R Pfundt, PG van der Valk, ...
Journal of investigative dermatology 125 (6), 1163-1173, 2005
3602005
Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
PCM van de Kerkhof, CEM Griffiths, K Reich, CL Leonardi, A Blauvelt, ...
Journal of the American Academy of Dermatology 75 (1), 83-98. e4, 2016
3292016
Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie, WHPM Vissers, MCW Creemers, EMGJ de Jong, ...
Arthritis research & therapy 7, 1-11, 2005
3192005
High prevalence of foot diseases in Europe: results of the Achilles Project
T Burzykowski, G Molenberghs, D Abeck, E Haneke, R Hay, A Katsambas, ...
Mycoses 46 (11‐12), 496-505, 2003
3102003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20